Tumor-derived exosomes as promising tools for cancer diagnosis and therapy

Mounting evidences indicated that cancer cell-derived exosomes (TDEs) contribute to cancer progression and metastasis by reshaping the tumor microenvironment (TME) and interfering immunity response. TDEs contain unique biomolecular cargo, consisting of protein, nucleic acid, and lipids. In recent ye...

Full description

Saved in:
Bibliographic Details
Main Authors: Xirui Wang, Yanfang Liu, Yaowen Jiang, Qinghua Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1596217/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849321450891116544
author Xirui Wang
Yanfang Liu
Yaowen Jiang
Qinghua Li
author_facet Xirui Wang
Yanfang Liu
Yaowen Jiang
Qinghua Li
author_sort Xirui Wang
collection DOAJ
description Mounting evidences indicated that cancer cell-derived exosomes (TDEs) contribute to cancer progression and metastasis by reshaping the tumor microenvironment (TME) and interfering immunity response. TDEs contain unique biomolecular cargo, consisting of protein, nucleic acid, and lipids. In recent years, TDEs have been used as potential disease therapeutics and diagnosis biomarkers and prime candidates as delivery tools for cancer treatment. In the present review, we firstly summarized TDEs biogenesis and characteristic. Also, the role of TDEs in cancer cell metastasis and invasiveness, drug resistance, and immunosuppression was mentioned via cell-cell communication. Additionally, we concluded the current strategies for TDE-based cancer therapy, including TDEs inhibition and clearance, usage as therapeutic drug delivery vector and cancer vaccines. Furthermore, combination therapy with engineered TDEs were summarized, such as radiotherapy, photodynamic therapy, photothermal therapy, and sonodynamic therapy. Consequently, the above opens up novel and interesting opportunities for cancer diagnosis and prognosis based on TDEs, which is prospective to accelerate the clinical translation of TDEs for cancer therapy.
format Article
id doaj-art-ab6bb115577f4eeca3b69e7df8cde6d3
institution Kabale University
issn 1663-9812
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-ab6bb115577f4eeca3b69e7df8cde6d32025-08-20T03:49:45ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-05-011610.3389/fphar.2025.15962171596217Tumor-derived exosomes as promising tools for cancer diagnosis and therapyXirui Wang0Yanfang Liu1Yaowen Jiang2Qinghua Li3Department of Biomedical Engineering, School of Medical Imaging Xuzhou Medical University, Xuzhou, ChinaDepartment of Central Laboratory, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, ChinaDepartment of Biomedical Engineering, School of Medical Imaging Xuzhou Medical University, Xuzhou, ChinaInstitute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang, ChinaMounting evidences indicated that cancer cell-derived exosomes (TDEs) contribute to cancer progression and metastasis by reshaping the tumor microenvironment (TME) and interfering immunity response. TDEs contain unique biomolecular cargo, consisting of protein, nucleic acid, and lipids. In recent years, TDEs have been used as potential disease therapeutics and diagnosis biomarkers and prime candidates as delivery tools for cancer treatment. In the present review, we firstly summarized TDEs biogenesis and characteristic. Also, the role of TDEs in cancer cell metastasis and invasiveness, drug resistance, and immunosuppression was mentioned via cell-cell communication. Additionally, we concluded the current strategies for TDE-based cancer therapy, including TDEs inhibition and clearance, usage as therapeutic drug delivery vector and cancer vaccines. Furthermore, combination therapy with engineered TDEs were summarized, such as radiotherapy, photodynamic therapy, photothermal therapy, and sonodynamic therapy. Consequently, the above opens up novel and interesting opportunities for cancer diagnosis and prognosis based on TDEs, which is prospective to accelerate the clinical translation of TDEs for cancer therapy.https://www.frontiersin.org/articles/10.3389/fphar.2025.1596217/fulltumor-derived exosomescancer diagnosiscancer vaccinecancer therapydrug deliveryengineered exosomes
spellingShingle Xirui Wang
Yanfang Liu
Yaowen Jiang
Qinghua Li
Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
Frontiers in Pharmacology
tumor-derived exosomes
cancer diagnosis
cancer vaccine
cancer therapy
drug delivery
engineered exosomes
title Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
title_full Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
title_fullStr Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
title_full_unstemmed Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
title_short Tumor-derived exosomes as promising tools for cancer diagnosis and therapy
title_sort tumor derived exosomes as promising tools for cancer diagnosis and therapy
topic tumor-derived exosomes
cancer diagnosis
cancer vaccine
cancer therapy
drug delivery
engineered exosomes
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1596217/full
work_keys_str_mv AT xiruiwang tumorderivedexosomesaspromisingtoolsforcancerdiagnosisandtherapy
AT yanfangliu tumorderivedexosomesaspromisingtoolsforcancerdiagnosisandtherapy
AT yaowenjiang tumorderivedexosomesaspromisingtoolsforcancerdiagnosisandtherapy
AT qinghuali tumorderivedexosomesaspromisingtoolsforcancerdiagnosisandtherapy